| Medical and Health Sciences | Lifetime | 277 | FI 2 | 99.99 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 16 | FI 2 | 99.93 |
| Public, Environmental and Occupational Health | Lifetime | 372 | FI 4 | 99.47 |
| Cardiology and Cardiovascular Medicine | Lifetime | 451 | FI 4 | 99.37 |
| Medical Physiology | Lifetime | 548 | FI 4 | 99.07 |
| Epidemiology | Lifetime | 722 | FI 4 | 99.05 |
| Clinical Pharmacology | Lifetime | 400 | FI 5 | 98.31 |
| Pharmacy | Lifetime | 193 | FI 6 | 97.63 |
| Nutrition and Dietetics | Lifetime | 892 | FI 16 | 95.60 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 219 | FI 1 | 96.10 |
| Medical Physiology | 2021-2025 | 755 | FI 7 | 87.93 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 15 | FI 2 | 99.91 |
| Metabolism, Diabetes, and Cancer | Lifetime | 47 | FI 3 | 99.73 |
| Diabetes Management and Education | Lifetime | 21 | FI 1 | 99.57 |
| Blood Pressure and Hypertension Studies | Lifetime | 82 | FI 1 | 99.64 |
| Diet and metabolism studies | Lifetime | 181 | FI 5 | 99.56 |
| Diabetes Treatment and Management | Lifetime | 88 | FI 4 | 99.57 |
| Diabetes Management and Research | Lifetime | 109 | FI 5 | 99.50 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 24 | FI 3 | 99.26 |
| Pharmacology and Obesity Treatment | Lifetime | 44 | FI 1 | 99.26 |
| Liver Disease Diagnosis and Treatment | Lifetime | 498 | FI 5 | 99.31 |
| Cardiovascular Health and Risk Factors | Lifetime | 47 | FI 1 | 99.14 |
| Nutritional Studies and Diet | Lifetime | 164 | FI 3 | 99.33 |
| Coffee research and impacts | Lifetime | 25 | FI 1 | 98.49 |
| Obesity, Physical Activity, Diet | Lifetime | 249 | FI 4 | 99.31 |
| Diabetes and associated disorders | Lifetime | 260 | FI 11 | 98.76 |
| Cardiovascular Disease and Adiposity | Lifetime | 211 | FI 5 | 98.78 |
| Birth, Development, and Health | Lifetime | 390 | FI 10 | 98.80 |
| Diet, Metabolism, and Disease | Lifetime | 225 | FI 6 | 98.68 |
| Global Public Health Policies and Epidemiology | Lifetime | 117 | FI 2 | 98.37 |
| Lipoproteins and Cardiovascular Health | Lifetime | 241 | FI 9 | 98.86 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | Lifetime | 147 | FI 3 | 97.75 |
| Chronic Disease Management Strategies | Lifetime | 289 | FI 1 | 97.92 |
| Adipokines, Inflammation, and Metabolic Diseases | Lifetime | 478 | FI 9 | 97.98 |
| Obesity and Health Practices | Lifetime | 215 | FI 2 | 97.70 |
| Acute Ischemic Stroke Management | Lifetime | 818 | FI 9 | 97.84 |
| Sodium Intake and Health | Lifetime | 135 | FI 2 | 97.69 |
| Physical Activity and Health | Lifetime | 455 | FI 14 | 97.09 |
| Cardiovascular Health and Disease Prevention | Lifetime | 897 | FI 19 | 96.36 |
| Dietary Effects on Health | Lifetime | 788 | FI 3 | 88.52 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | 2021-2025 | 115 | FI 3 | 96.55 |
| Diabetes Management and Education | 2021-2025 | 181 | FI 1 | 91.48 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 498 | FI 2 | 87.16 |
| Obesity and Health Practices | 2021-2025 | 418 | FI 2 | 82.15 |
